• How we work
    • Software
    • Smarts
    • Service
  • Solutions
    • Mapping
    • Measuring
    • Monitoring
  • Insights
    • Latest thinking
    • Resources
  • About
    • Who we are
    • Team
    • Careers
    • Contact us
  • Client login
ESMO 2022: How Did An Oncology Congress Manage to Create Media Buzz?

ESMO 2022: How Did An Oncology Congress Manage to Create Media Buzz?

by Commetric | Sep 26, 2022 | Blog

This year’s European Society for Medical Oncology (ESMO) Congress was closely followed by specialised pharma outlets and managed to generate interest in daily media as well. Our media analysis found that a new study linking pollution...
Why Did a Study on Depression Cause a Media Frenzy? Insights from the Recent Debate Around Antidepressants

Why Did a Study on Depression Cause a Media Frenzy? Insights from the Recent Debate Around Antidepressants

by Commetric | Aug 5, 2022 | Blog

A new UCL study made headlines for “debunking” the serotonin imbalance theory of depression and caused a Twitter storm. Our media analysis found that the reaction from many researchers suggested that the serotonin imbalance theory has not been treated seriously...
EHA 2022: What Hematology Trends Attracted Media Attention [Infographic]

EHA 2022: What Hematology Trends Attracted Media Attention [Infographic]

by Commetric | Jul 27, 2022 | Blog

The European Hematology Association’s (EHA) 2022 Hybrid Congress was covered widely by specialised pharma media outlets like Hematology Advisor, Fierce Biotech and Medscape, as well as some business publications like Reuters and Seeking Alpha. To see what stood out...
EHA 2022: What Hematology Trends Attracted Media Attention?

EHA 2022: What Hematology Trends Attracted Media Attention?

by Commetric | Jul 22, 2022 | Blog

The European Hematology Association’s 2022 Congress saw many pharma companies present their latest work in blood cancer research. Our analysis found that lymphoma became the focus of the media debate around EHA 2022, while companies that reported M&A deals...
ASCO 2022: What Are the PR Takeaways from Oncology’s Biggest Event?

ASCO 2022: What Are the PR Takeaways from Oncology’s Biggest Event?

by Commetric | Jul 4, 2022 | Blog

The first meeting of the American Society of Clinical Oncology since the start of the pandemic was covered by many pharma publications which followed a wealth of exciting data across the oncology spectrum. Our media analysis found that ASCO gave rise to a new...
Prev12345Next

Recent Posts

  • Commetric triumphs at the DataComms Awards 2025
  • When is a Newsletter NOT a Newsletter?
  • Commetric shortlisted for two DataComms Awards 2025
  • Commetric Announces Leadership Changes: Solheim as Non-Executive Chairman, Minkovski as Interim CEO
  • From product to process: how the FMCG sustainability communications evolved

Tags

AI AMEC Brand management Climate Change Consumer Trends Corporate Communication Corporate Reputation COVID-19 Business Impact Tracker Crisis Communications Crisis Management Digital Marketing Diversity and Inclusion ESG Fashion Financial Services Food and Drink Health & Wellness Health and Wellness Immunotherapy Influencer Marketing Influencer Network Analysis Media Analytics Media Intelligence Media Monitoring Net Zero Oncology Pharma PR PR Analytics Precision Medicine PR Measurement PR Strategy Public Affairs Public Relations Regeneration Reputation Management Social Media Social Media Analytics Social Media Marketing Sports Strategic Communications Sustainability Tech Technology Twitter

How we work

Software

Smarts

Service

Solutions

Mapping

Measuring

Monitoring

Information

Insights

Resources

Who we are

Team

Careers

Privacy Policy

GDPR Policy

Contact

E-mail:
info@commetric.com

Phone:
+44 (0) 845 287 3003

  • Follow
  • Follow
Copyright ©2025 Commetric